These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1347 related items for PubMed ID: 26637807
1. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway. Kim S, Lee J, Jeon M, Lee JE, Nam SJ. Oncotarget; 2016 Jan 12; 7(2):1544-58. PubMed ID: 26637807 [Abstract] [Full Text] [Related]
2. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells. Kim S, Lee J, Jeon M, Nam SJ, Lee JE. Cytokine; 2015 Sep 12; 75(1):151-8. PubMed ID: 26088755 [Abstract] [Full Text] [Related]
7. Zerumbone suppresses IL-1β-induced cell migration and invasion by inhibiting IL-8 and MMP-3 expression in human triple-negative breast cancer cells. Han J, Bae SY, Oh SJ, Lee J, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Nam SJ, Kim S, Lee JE. Phytother Res; 2014 Nov 12; 28(11):1654-60. PubMed ID: 24890258 [Abstract] [Full Text] [Related]
16. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. Liang S, Chen Z, Jiang G, Zhou Y, Liu Q, Su Q, Wei W, Du J, Wang H. Cancer Lett; 2017 Feb 01; 386():12-23. PubMed ID: 27836733 [Abstract] [Full Text] [Related]
17. Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis. Zhu X, Wang K, Chen Y. Toxicol In Vitro; 2020 Dec 01; 69():104973. PubMed ID: 32818624 [Abstract] [Full Text] [Related]
18. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor. Park SJ, Choi YS, Lee S, Lee YJ, Hong S, Han S, Kim BC. Cancer Lett; 2016 Oct 28; 381(2):314-22. PubMed ID: 27543359 [Abstract] [Full Text] [Related]